We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$39.6B
AUM Growth
+$3.93B
Cap. Flow
+$750M
Cap. Flow %
1.89%
Top 10 Hldgs %
5.74%
Holding
1,868
New
87
Increased
789
Reduced
836
Closed
75

Top Buys

Rank Stock Value
1
PF
Pinnacle Foods, Inc.
PF
+$140M
2
BWA icon
BorgWarner
BWA
+$110M
3
HCA icon
HCA Healthcare
HCA
+$97.3M
4
TXT icon
Textron
TXT
+$94.4M
5
WAB icon
Wabtec
WAB
+$88.8M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Industrials 15.25%
3 Technology 14.39%
4 Consumer Discretionary 9.34%
5 Healthcare 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNCR icon
1701
Xencor
XNCR
$1.55B
$26K ﹤0.01%
975
-577
-37% -$13.9K
CRIS icon
1702
Curis
CRIS
$7.83M
$24K ﹤0.01%
4
PTLA
1703
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$24K ﹤0.01%
1,049
+59
+6% +$1.15K
SGYP
1704
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$24K ﹤0.01%
3,983
+332
+9% +$1.74K
DQ
1705
Daqo New Energy
DQ
$996M
$23K ﹤0.01%
6,030
RARE icon
1706
Ultragenyx Pharmaceutical
RARE
$2.55B
$23K ﹤0.01%
322
+28
+10% +$1.99K
DPLO
1707
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$23K ﹤0.01%
1,811
-43
-2% -$801
ACFC
1708
DELISTED
Atlantic Coast Financial Corporation
ACFC
$23K ﹤0.01%
3,362
IONS icon
1709
Ionis Pharmaceuticals
IONS
$9.4B
$22K ﹤0.01%
+454
New +$18K
MOMO
1710
Hello Group
MOMO
$866M
$22K ﹤0.01%
+1,201
New +$26.5K
HOLI
1711
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$22K ﹤0.01%
1,215
FOMX
1712
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$22K ﹤0.01%
1,998
+111
+6% +$1.04K
CBPO
1713
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$22K ﹤0.01%
+206
New +$24.1K
LXRX icon
1714
Lexicon Pharmaceuticals
LXRX
$1.1B
$21K ﹤0.01%
1,530
+86
+6% +$1.38K
EMKR
1715
DELISTED
Emcore Corp
EMKR
$21K ﹤0.01%
+239
New +$16.4K
LCNB icon
1716
LCNB Corp
LCNB
$283M
$20K ﹤0.01%
865
JOYY
1717
JOYY Inc
JOYY
$3.75B
$20K ﹤0.01%
+503
New +$23.6K
MLNX
1718
DELISTED
Mellanox Technologies, Ltd.
MLNX
$20K ﹤0.01%
478
-124,837
-100% -$5.28M
GNMX
1719
DELISTED
Aevi Genomic Medicine Inc
GNMX
$20K ﹤0.01%
3,863
+322
+9% +$1.69K
NVEE
1720
DELISTED
NV5 Global
NVEE
$19K ﹤0.01%
2,304
CORI
1721
DELISTED
Corium International, Inc.
CORI
$19K ﹤0.01%
4,606
+255
+6% +$1.27K
ADMS
1722
DELISTED
Adamas Pharmaceuticals
ADMS
$18K ﹤0.01%
1,062
+60
+6% +$928
CDTX
1723
DELISTED
Cidara Therapeutics
CDTX
$17K ﹤0.01%
+82
New +$17K
RIGL icon
1724
Rigel Pharmaceuticals
RIGL
$750M
$17K ﹤0.01%
699
+39
+6% +$1.12K
MBLY
1725
DELISTED
Mobileye N.V.
MBLY
$17K ﹤0.01%
458
-1,028
-69% -$38.7K

Similar funds

Victory Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Victory Capital Management held 1,868 positions worth $39.6B, up 11% from $35.7B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.

Victory Capital Management's Q4 2016 filing shows 87 new, 789 increased, 836 reduced and 75 closed positions. Its largest new stake was Alkermes: 1,286,507 shares worth $71.5M. The largest sale was Sealed Air, an estimated $125M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

  • Victory Capital Management's largest Q4 2016 buy was Alkermes: 1,286,507 shares worth $71.5M.
  • Victory Capital Management added most to Pinnacle Foods, Inc. in Q4 2016, an estimated $140M increase.
  • Victory Capital Management's biggest Q4 2016 reduction was Sealed Air, cutting an estimated $125M.
  • Victory Capital Management fully exited Endurance Specialty Holdings Ltd in Q4 2016, selling an estimated $97.5M.
  • Victory Capital Management's ten largest holdings make up 5.7% of its $39.6B portfolio in Q4 2016.
  • Victory Capital Management opened 87 new positions and closed 75 in Q4 2016.
  • Victory Capital Management's portfolio value rose 11% quarter-over-quarter to $39.6B.

Based on Victory Capital Management's 13F filing for Q4 2016, filed 9 Feb 2017.